{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:22:50Z","timestamp":1790425370874,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["GIA\/48\/2014-DHR"],"award-info":[{"award-number":["GIA\/48\/2014-DHR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01080","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T04:15:28Z","timestamp":1526530528000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Shubham","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smrity","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana W.","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young M.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biman","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT 3 mutation in the hyper IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT 3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.20082767","article-title":"Molecular explanation for the contradiction between systemic TH17 defect & localized bacterial infection in hyper-IgE syndrome","volume":"206","author":"Minegishi","year":"2009","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections \u2013 an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0091-6749(96)80202-8","article-title":"Previously undiagnosed hyper-IgE syndrome in an adult with multiple systemic fungal infections","volume":"98","author":"Desai","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000247728","article-title":"Variant of hyper IgE syndrome: the differentiation from atopic dermatitis is important because of treatment and prognosis","volume":"182","author":"Hochreutener","year":"1991","journal-title":"Dermatologica"},{"key":"B9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(74)91942-4","article-title":"Defect in neutrophil granulocyte chemotaxis in Job\u2019s syndrome of recurrent \u2018cold\u2019 staphylococcal abscesses","volume":"2","author":"Hill","year":"1974","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0140-6736(89)90759-9","article-title":"Hyper IgE syndrome and H2-receptor blockade","volume":"2","author":"Thompson","year":"1989","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.2011.06387.x","article-title":"Hyper-IgE syndrome update","volume":"1250","author":"Sowerwine","year":"2012","journal-title":"Ann N Y AcadSci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/BF00441793","article-title":"Craniosynostosis in hyper-IgE syndrome","volume":"144","author":"H\u00f6ger","year":"1985","journal-title":"Eur J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jemt.10370","article-title":"Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption","volume":"61","author":"Sasaki","year":"2003","journal-title":"Microsc Res Tech"},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A genetic-pathophysiological framework of craniosynostosis","volume":"97","author":"Stephen","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B19","first-page":"403","article-title":"Histomorphologic changes in the gingival and pulp of overretained primary teeth","volume":"67","author":"Bimbstein","year":"2000","journal-title":"ASDC J Dent Child"},{"key":"B20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","article-title":"New developments in osteoimmunology","volume":"8","author":"Takayanagi","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/jid.2008.139","article-title":"Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22","volume":"128","author":"Eyerich","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.12932\/AP0456.32.4.2014","article-title":"Hyper-IgE syndrome with a novel STAT3 mutation \u2013 a single center study from India","volume":"32","author":"Saikia","year":"2014","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12098-017-2336-y","article-title":"Novel mutation in SH2 domain of STAT3 (p.M660T) in hyper-IgE syndrome with sterno-clavicular and paravertebral abscesses","volume":"84","author":"Saikia","year":"2017","journal-title":"Indian J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P","article-title":"STAT3 mediates IL-6 induced growth inhibition in the human prostate cancer cell line LNCap","volume":"41","author":"Spiotto","year":"2000","journal-title":"Prostate"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.onc.1206247","article-title":"Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays","volume":"22","author":"Clark","year":"2003","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G","article-title":"Interleukin-6 induces prostate cancer cell growth accompanied by activation of STAT3 signaling pathway","volume":"42","author":"Lou","year":"2000","journal-title":"Prostate"},{"key":"B28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12038-012-9202-x","article-title":"STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6\/STAT3 signalling pathway","volume":"37","author":"He","year":"2012","journal-title":"J Biosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1074\/jbc.M709960200","article-title":"NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages","volume":"283","author":"Narayana","year":"2008","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"76491","DOI":"10.1371\/journal.pone.0076491","article-title":"The immune-regulatory impact of orally-administered Hypericum perforatum on Balb\/c mice inoculated with H1N1 influenza virus","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00204-011-0782-2","article-title":"Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells","volume":"86","author":"Pal","year":"2012","journal-title":"Arch Toxicol"},{"key":"B32","first-page":"2271","article-title":"Osteopontin: possible role in prostate cancer progression","volume":"5","author":"Thalmann","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e6911","DOI":"10.1371\/journal.pone.0006911","article-title":"Prediction and experimental validation of novel STAT3 target genes in human cancer cells","volume":"4","author":"Oh","year":"2009","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gkr1252","article-title":"Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices","volume":"40","author":"Oh","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1515\/hsz-2013-0166","article-title":"Interleukin-6 and interleukin-11: same same but different","volume":"349","author":"Garbers","year":"2013","journal-title":"Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5306\/wjco.v2.i12.384","article-title":"IL-6\/IL-6R as a potential key signaling pathway in prostate cancer development","volume":"2","author":"Azevedo","year":"2011","journal-title":"World J Clin Oncol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5772\/53110","article-title":"The importance of cancer cell lines as in vitro models in cancer methylome analysis and anticancer drugs testing","volume-title":"Oncogenomics and cancer proteomics - novel approaches in biomarkers discovery and therapeutic targets in cancer","author":"Ferreira","year":"2013"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/thy.2009.0195","article-title":"Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer","volume":"19","author":"Pilli","year":"2009","journal-title":"Thyroid"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/clim.2001.5039","article-title":"Cytokine and chemokine dysregulation in hyper-IgE syndrome","volume":"100","author":"Chehimi","year":"2001","journal-title":"Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.chembiol.2006.11.001","article-title":"A new small-molecule Stat3 inhibitor","volume":"13","author":"McMurray","year":"2006","journal-title":"Chem Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e54565","DOI":"10.1371\/journal.pone.0054565","article-title":"Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma","volume":"8","author":"Pan","year":"2013","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1210\/jc.2007-0349","article-title":"Plasma osteopontin levels and expression in adipose tissue are increased in obesity","volume":"92","author":"G\u00f3mez-Ambrosi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/154405910608500503","article-title":"Osteopontin and mucosal protection","volume":"85","author":"Sodek","year":"2006","journal-title":"J Dent Res"},{"key":"B46","first-page":"36","article-title":"Osteopontin regulation by protein kinase B (AKT) in HepG2 cells","volume":"28","author":"Zhang","year":"2006","journal-title":"Exp Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1189\/jlb.0412194","article-title":"Dual regulation of osteopontin production by TLR stimulation in dendritic cells","volume":"94","author":"Salvi","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/eji.200838879","article-title":"Regulatory effects of IFN-\u03b2 on production of osteopontin and IL-17 by CD4+ T cells in MS","volume":"39","author":"Chen","year":"2009","journal-title":"Eur J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.18632\/oncotarget.21021","article-title":"Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","article-title":"Osteopontin: role in cell signaling and cancer progression","volume":"16","author":"Rangaswami","year":"2006","journal-title":"Trends Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgp289","article-title":"Activation of JAK2\/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells","volume":"31","author":"Behera","year":"2010","journal-title":"Carcinogenesis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.4049\/jimmunol.1004019","article-title":"Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms","volume":"187","author":"Oh","year":"2011","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/jcp.21250","article-title":"OPN deficiency suppresses appearance of odontoclastic cells and resorption of the tooth root induced by experimental force application","volume":"14","author":"Chung","year":"2008","journal-title":"J Cell Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajodo.2004.11.030","article-title":"Inhibition of orthodontically induced root resorption with echistatin, an RGD-containing peptide","volume":"129","author":"Talic","year":"2006","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"B55","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/154405910308200905","article-title":"Effects of echistatin and an RGD peptide on orthodontic tooth movement","volume":"82","author":"Dolce","year":"2003","journal-title":"J Dent Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.bone.2010.08.025","article-title":"Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption","volume":"47","author":"Walker","year":"2010","journal-title":"Bone"},{"key":"B57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jor.20544","article-title":"Altered osteoclast development and function in osteopontin deficient mice","volume":"26","author":"Franz\u00e9n","year":"2008","journal-title":"J Orthop Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1091\/mbc.E02-06-0354","article-title":"Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression","volume":"14","author":"Chellaiah","year":"2003","journal-title":"Mol Biol Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1359\/jbmr.1998.13.7.1101","article-title":"Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro","volume":"13","author":"Rittling","year":"1998","journal-title":"J Bone Miner Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T04:15:33Z","timestamp":1526530533000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2018.01080"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01080","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"article-number":"1080"}}